Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Interest Expenses (2016 - 2017)

Historic Interest Expenses for Corcept Therapeutics (CORT) over the last 5 years, with Q2 2017 value amounting to $98000.0.

  • Corcept Therapeutics' Interest Expenses fell 8154.43% to $98000.0 in Q2 2017 from the same period last year, while for Mar 2018 it was $98000.0, marking a year-over-year decrease of 8154.43%. This contributed to the annual value of $25000.0 for FY2011, which is 0.0% changed from last year.
  • Latest data reveals that Corcept Therapeutics reported Interest Expenses of $98000.0 as of Q2 2017, which was down 8154.43% from $531000.0 recorded in Q2 2016.
  • Corcept Therapeutics' Interest Expenses' 5-year high stood at $531000.0 during Q2 2016, with a 5-year trough of $98000.0 in Q2 2017.